FDA Drug Application (202179) for PREDNISOLONE SODIUM PHOSPHATE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202179
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
DosageEQ 10MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePREDNISOLONE SODIUM PHOSPHATE
Active IngredientPREDNISOLONE SODIUM PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient PREDNISOLONE SODIUM PHOSPHATE14


Back to FDA Applications sponsored by MYLAN PHARMS INC